ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Effects of Motivating People With Schizophrenia to Exercise

This study is currently recruiting participants.
Information provided by National Institute of Mental Health (NIMH)

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  Effects of Motivating People With Schizophrenia to Exercise
Official Title  Motivating Persons With Schizophrenia to Exercise
Brief Summary

This study will evaluate the impact of motivational guidance to exercise on people with schizophrenia, based on their participation in a walking program.

Detailed Description

Schizophrenia is a chronic brain disorder that affects about 1% of Americans. People with schizophrenia experience extreme paranoia, often claiming that they hear voices not heard by others and that others are invading or controlling their minds with the intent to hurt them. More specific symptoms include hallucinations, delusional behaviors, disordered movements, and decreased ability to comprehend and apply information to everyday activities. The severity of these symptoms makes self-care and regular exercise difficult for people with schizophrenia. The fatality rate from diabetes, heart disease, and other obesity-related illnesses is significantly higher in people with schizophrenia. Exercise is known to reduce health problems associated with obesity, yet few studies have encouraged exercise as a treatment method for improving the health of those with schizophrenia. Furthermore, the long-term physical and mental effects of consistent exercise on people with schizophrenia are not well-known. This study will evaluate the impact of motivational guidance to exercise on people with schizophrenia, based on their attendance, persistence, and compliance to a walking program.

Participants in this study will be randomly assigned to one of two groups. Both groups will continue their regular medications and treatments throughout the study. Upon entry, members of both groups will complete the same two forms concerning attitudes toward exercise. Group 1 participants will attend weekly 1-hour exercise information sessions for 4 weeks. Group 2 participants will attend weekly 1-hour general health information sessions for the same 4 weeks. Participants of both groups will then take part in identical 16-week walking programs. The walking program will consist of three 30- to 50-minute walks per week, including 10 minutes of warm up and 10 minutes of cool down stretching. All participants will gradually increase their walking time from 5 minutes to 30 minutes during the program. At the completion of the walking programs, participants of both groups will complete repeat forms about their attitudes toward exercise. There will be no follow-up visits for the participants.

Study Phase
Study Type  Interventional
Study Design  Treatment, Randomized, Single Blind (Investigator), Active Control, Parallel Assignment, Safety/Efficacy Study
Primary Outcome Measure  Exercise group attendance [ Time Frame: Measured at Week 16 ] [ Designated as safety issue: No ]
Exercise group persistence [ Time Frame: Measured at Weeks 4,8, 12 & 16 ] [ Designated as safety issue: No ]
Exercise group compliance [ Time Frame: Measured at Weeks 4,8,12 & 16 ] [ Designated as safety issue: No ]
Exercise attitude [ Time Frame: Measured at Weeks 4,8,12 and 16 ] [ Designated as safety issue: No ]
Secondary Outcome Measure 
Condition  Schizophrenia
Intervention  Behavioral: Motivational group sessions
Other: Time and attention control group sessions
MEDLINE PMIDs
Links
Recruitment Information Fields
Recruitment Status  Recruiting
Enrollment  80
Start Date  November 2007
Completion Date August 2009
Eligibility Criteria 

Inclusion Criteria:

  • Meets DSM-IV criteria for schizophrenia
  • Speaks English
  • Stable medication regimen
  • Able to receive medical clearance for moderate exercise

Exclusion Criteria:

  • Hospitalized within 1 year of study entry for angina, heart attack, or cardiac surgery
  • Diagnosed with congestive heart failure
  • Has a pacemaker
  • Heart rate less than 50 bpm or more than 100 bpm at rest
  • Uncontrolled hypertension
  • History of spinal or hip fracture
  • Unable to walk or move around without assistance
  • Any other medical condition, in the opinion of primary care provider, that would prevent safe participation in the study
Gender Both
Ages 22 Years and older
Accepts Healthy Volunteers No
Contacts ††
Contact: Lora L. Beebe, Phd, PMHNP-BC     865-974-3978     lbeebe1@utk.edu    
Location Countries  United States
Administrative Information Fields
NCT ID  NCT00559572
Organization ID R03 MH079047
Secondary IDs ††
Study Sponsor  National Institute of Mental Health (NIMH)
Collaborators ††
Investigators 
Principal Investigator:     Lora L. Beebe, PhD, PMHNP, BC     University of Tennessee    
Information Provided By National Institute of Mental Health (NIMH)
Verification Date August 2008
First Received Date  November 14, 2007
Last Updated Date August 19, 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers